Regencell Bioscience Holdings Ltd. (RGC): Price and Financial Metrics

Regencell Bioscience Holdings Ltd. (RGC): $25.79

0.00 (0.00%)

POWR Rating

Component Grades













RGC Stock Price Chart Interactive Chart >

Price chart for RGC

RGC Price/Volume Stats

Current price $25.79 52-week high $48.29
Prev. close $26.90 52-week low $20.54
Day low $25.79 Volume 100
Day high $25.79 Avg. volume 1,186
50-day MA $28.61 Dividend yield N/A
200-day MA $29.95 Market Cap 326.04M

Regencell Bioscience Holdings Ltd. (RGC) Company Bio

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

RGC Latest News Stream

Event/Time News Detail
Loading, please wait...

RGC Latest Social Stream

Loading social stream, please wait...

View Full RGC Social Stream

Latest RGC News From Around the Web

Below are the latest news stories about REGENCELL BIOSCIENCE HOLDINGS LTD that investors may wish to consider to help them evaluate RGC as an investment opportunity.

With 81% ownership, Regencell Bioscience Holdings Limited (NASDAQ:RGC) insiders have a lot riding on the company's future

Key Insights Insiders appear to have a vested interest in Regencell Bioscience Holdings' growth, as seen by their...

Yahoo | February 21, 2023

Companies Like Regencell Bioscience Holdings (NASDAQ:RGC) Are In A Position To Invest In Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...

Yahoo | November 21, 2022

RGC: Forging a New Approach to ADHD and ASD

By Brad Sorensen, CFA NASDAQ:RGC Traditional “western” medicine has made amazing advances and is one of the great innovations in history, but, unfortunately, there are still many conditions afflicting people that western medicine hasn’t been able to treat with any great effectiveness. It’s in instances like these that it can be beneficial to look to a medical approach that’s been around for over

Yahoo | November 15, 2022

One Regencell Bioscience Holdings Limited (NASDAQ:RGC) insider upped their stake by 1.4% in the previous year

Insiders were net buyers of Regencell Bioscience Holdings Limited's ( NASDAQ:RGC ) stock during the past year. That is...

Yahoo | October 25, 2022

81% of Regencell Bioscience Holdings Limited (NASDAQ:RGC) is owned by insiders, and they've been buying recently

Every investor in Regencell Bioscience Holdings Limited ( NASDAQ:RGC ) should be aware of the most powerful shareholder...

Yahoo | September 14, 2022

Read More 'RGC' Stories Here

RGC Price Returns

1-mo N/A
3-mo -11.68%
6-mo -11.07%
1-year -15.91%
3-year N/A
5-year N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7977 seconds.